胃癌组织中PIM—3的异常表达及临床意义(4)
| 第1页 |
参见附件。
[16] Wang C，Li HY，Liu B，et al. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor [J]. J Surg Res，2013，185(2)：595-604.
[17] Xu D，Cobb MG，Gavilano L，et al. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine [J]. Cancer Biol Ther，2013，14(6)：492-501.
[18] Wang Z，Li XM，Shang K，et al. T-18，a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis，acting as a potent anticancer drug [J]. Oncol Rep，2013，29(3)：1245-1251.
[19] Liu LM，Sun SL，Ye CG，et al. Inhibitive mechanisms of Pim-3 affecting fulminant hepatic apoptosis [J]. Zhonghua Gan Zang Bing Za Zhi，2012，20(9)：688-692.
[20] Narlik-Grassow M，Blanco-Aparicio C，Cecilia Y，et al. The essential role of PIM kinases in sarcoma growth and bone invasion [J]. Carcinogenesis，2012，33(8)：1479-1486.
[21] 邵雪辉，王建国，张晓丽，等.红外线对萎缩性胃炎大鼠PCNA及Bcl-2表达的影响[J].北京生物医学工程，2012， 31(1)：87-89.
[22] Zheng HC，Tsuneyama K，Takahashi H，et al. Aberrant Pim-3 expressionis involved in gastric adenoma-adenocarcinomasequence and cancer progression [J]. J Cancer Res Clin Oncol，2008，134(1)：481-488.
(收稿日期：2014-07-28 本文编辑：任 念)
您现在查看是摘要介绍页，详见PDF附件。